House Bill No. by Representative Glorioso aims to prohibit prior authorization requirements for certain generic medications prescribed by qualified physicians, specifically board-certified physicians. The bill introduces new definitions, including "board-certified physician," "commercial insurer," "generic medication," and "prior authorization," which clarify the terms used in the legislation. It mandates that commercial insurers and Medicaid managed care organizations cannot require prior authorization for the dispensing or reimbursement of generic medications if prescribed by a board-certified physician whose specialty aligns with the medical indication for the drug.

The provisions of this bill will apply to any new health insurance policies, contracts, or Medicaid managed care agreements issued on or after January 1, 2027. Existing policies and contracts in effect prior to this date must conform to the new requirements by their renewal date, but no later than January 1, 2028. This legislation is designed to streamline access to necessary medications for patients while ensuring that qualified physicians can prescribe them without additional bureaucratic hurdles.